Menu
GeneBe

chrX-56563955-G-C

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_013444.4(UBQLN2):ā€‹c.82G>Cā€‹(p.Ala28Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000232 in 1,161,790 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000089 ( 0 hom., 0 hem., cov: 23)
Exomes š‘“: 0.000025 ( 0 hom. 9 hem. )

Consequence

UBQLN2
NM_013444.4 missense

Scores

1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.46
Variant links:
Genes affected
UBQLN2 (HGNC:12509): (ubiquilin 2) This gene encodes an ubiquitin-like protein (ubiquilin) that shares high degree of similarity with related products in yeast, rat and frog. Ubiquilins contain a N-terminal ubiquitin-like domain and a C-terminal ubiquitin-associated domain. They physically associate with both proteasomes and ubiquitin ligases; and thus, are thought to functionally link the ubiquitination machinery to the proteasome to affect in vivo protein degradation. This ubiquilin has also been shown to bind the ATPase domain of the Hsp70-like Stch protein. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08049759).
BS2
High Hemizygotes in GnomAdExome4 at 9 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
UBQLN2NM_013444.4 linkuse as main transcriptc.82G>C p.Ala28Pro missense_variant 1/1 ENST00000338222.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
UBQLN2ENST00000338222.7 linkuse as main transcriptc.82G>C p.Ala28Pro missense_variant 1/1 NM_013444.4 P1

Frequencies

GnomAD3 genomes
AF:
0.00000887
AC:
1
AN:
112748
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34894
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000186
AC:
2
AN:
107547
Hom.:
0
AF XY:
0.0000570
AC XY:
2
AN XY:
35073
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000493
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000248
AC:
26
AN:
1049042
Hom.:
0
Cov.:
30
AF XY:
0.0000265
AC XY:
9
AN XY:
339146
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000319
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.00000887
AC:
1
AN:
112748
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34894
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Amyotrophic lateral sclerosis type 15 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 07, 2022This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 28 of the UBQLN2 protein (p.Ala28Pro). This variant is present in population databases (no rsID available, gnomAD 0.005%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with UBQLN2-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
16
DANN
Benign
0.88
DEOGEN2
Benign
0.035
T
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.67
T
M_CAP
Benign
0.0052
T
MetaRNN
Benign
0.080
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L
MutationTaster
Benign
1.0
N
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.032
Sift
Benign
0.13
T
Sift4G
Benign
0.27
T
Polyphen
0.0
B
Vest4
0.13
MutPred
0.21
Gain of glycosylation at A28 (P = 0.0042);
MVP
0.31
MPC
0.62
ClinPred
0.055
T
GERP RS
2.8
Varity_R
0.35
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1459753673; hg19: chrX-56590388; API